Akari Therapeutics Statistics
NASDAQ: AKTXHealthcareBiotechnologyUSD
8.13-0.495 (-5.74%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Akari Therapeutics by the numbers
Akari Therapeutics has a market capitalization of $18.6 million based on 2.29M shares outstanding. With trailing EPS of $0.00, Akari Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.8% below its 50-day average and 12.3% below its 200-day average.
Average daily trading volume is 61.08K shares, or about $496,597 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AKTX valuation vs. peer median
| Metric | AKTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $18.58M | $18.26M | +2% |
| Avg. volume | 61.08K | 130.73K | -53% |
Peer median across 8 companies: JSPR, ICU, ESLA, NEUP, NCEL, DYAI, QNTM, COCP.
Valuation
- Market cap
- $18.58M
- EPS (TTM)
- $0.00
- Shares outstanding
- 2.29M
Price and trading
- Previous close
- 8.63
- Open
- 8.37
- Day range
- 8.13 – 8.73
- 52-week range
- 3.02 – 40.00
- 52-week change
- -80.07%
- Beta
- —
- Volume
- 61.39K
- Average volume
- 61.08K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 18, 2025
Additional statistics
- Market Cap
- 18.58M
- Forward Pe
- -0.94
- Eps
- 0.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.00
- Week52 Low
- 3.02
- Avg Volume
- 61,082.00
- Shares Outstanding
- 2.29M
- Ma50
- 9.01
- Ma200
- 9.27
- Earnings Date
- Aug 18, 2025
- Pct From52w High
- -79.67%
- Pct From52w Low
- 169.65%